chr10-27167074-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001172303.3(MASTL):​c.812-28G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.999 in 1,593,372 control chromosomes in the GnomAD database, including 794,749 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.99 ( 75192 hom., cov: 31)
Exomes 𝑓: 1.0 ( 719557 hom. )

Consequence

MASTL
NM_001172303.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.101

Publications

7 publications found
Variant links:
Genes affected
MASTL (HGNC:19042): (microtubule associated serine/threonine kinase like) This gene encodes a microtubule-associated serine/threonine kinase. Mutations at this locus have been associated with autosomal dominant thrombocytopenia, also known as thrombocytopenia-2. Alternatively spliced transcript variants have been described for this locus. [provided by RefSeq, Feb 2010]
MASTL Gene-Disease associations (from GenCC):
  • autosomal thrombocytopenia with normal platelets
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 10-27167074-G-A is Benign according to our data. Variant chr10-27167074-G-A is described in CliVar as Benign. Clinvar id is 262127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-27167074-G-A is described in CliVar as Benign. Clinvar id is 262127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-27167074-G-A is described in CliVar as Benign. Clinvar id is 262127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-27167074-G-A is described in CliVar as Benign. Clinvar id is 262127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-27167074-G-A is described in CliVar as Benign. Clinvar id is 262127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-27167074-G-A is described in CliVar as Benign. Clinvar id is 262127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-27167074-G-A is described in CliVar as Benign. Clinvar id is 262127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-27167074-G-A is described in CliVar as Benign. Clinvar id is 262127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-27167074-G-A is described in CliVar as Benign. Clinvar id is 262127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-27167074-G-A is described in CliVar as Benign. Clinvar id is 262127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-27167074-G-A is described in CliVar as Benign. Clinvar id is 262127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-27167074-G-A is described in CliVar as Benign. Clinvar id is 262127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-27167074-G-A is described in CliVar as Benign. Clinvar id is 262127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-27167074-G-A is described in CliVar as Benign. Clinvar id is 262127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-27167074-G-A is described in CliVar as Benign. Clinvar id is 262127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-27167074-G-A is described in CliVar as Benign. Clinvar id is 262127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-27167074-G-A is described in CliVar as Benign. Clinvar id is 262127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-27167074-G-A is described in CliVar as Benign. Clinvar id is 262127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-27167074-G-A is described in CliVar as Benign. Clinvar id is 262127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-27167074-G-A is described in CliVar as Benign. Clinvar id is 262127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-27167074-G-A is described in CliVar as Benign. Clinvar id is 262127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-27167074-G-A is described in CliVar as Benign. Clinvar id is 262127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-27167074-G-A is described in CliVar as Benign. Clinvar id is 262127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.994 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MASTLNM_001172303.3 linkc.812-28G>A intron_variant Intron 6 of 11 ENST00000375940.9 NP_001165774.1 Q96GX5-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MASTLENST00000375940.9 linkc.812-28G>A intron_variant Intron 6 of 11 1 NM_001172303.3 ENSP00000365107.5 Q96GX5-1
MASTLENST00000375946.8 linkc.812-28G>A intron_variant Intron 6 of 11 1 ENSP00000365113.4 Q96GX5-3
MASTLENST00000342386.10 linkc.812-28G>A intron_variant Intron 6 of 10 2 ENSP00000343446.5 Q96GX5-2

Frequencies

GnomAD3 genomes
AF:
0.994
AC:
151220
AN:
152182
Hom.:
75138
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.978
Gnomad AMI
AF:
1.00
Gnomad AMR
AF:
0.997
Gnomad ASJ
AF:
1.00
Gnomad EAS
AF:
1.00
Gnomad SAS
AF:
1.00
Gnomad FIN
AF:
1.00
Gnomad MID
AF:
1.00
Gnomad NFE
AF:
1.00
Gnomad OTH
AF:
0.995
GnomAD2 exomes
AF:
0.998
AC:
250720
AN:
251112
AF XY:
0.999
show subpopulations
Gnomad AFR exome
AF:
0.979
Gnomad AMR exome
AF:
0.999
Gnomad ASJ exome
AF:
1.00
Gnomad EAS exome
AF:
1.00
Gnomad FIN exome
AF:
1.00
Gnomad NFE exome
AF:
1.00
Gnomad OTH exome
AF:
1.00
GnomAD4 exome
AF:
0.999
AC:
1440077
AN:
1441072
Hom.:
719557
Cov.:
26
AF XY:
0.999
AC XY:
717962
AN XY:
718386
show subpopulations
African (AFR)
AF:
0.976
AC:
32194
AN:
32994
American (AMR)
AF:
0.999
AC:
44645
AN:
44704
Ashkenazi Jewish (ASJ)
AF:
1.00
AC:
26012
AN:
26012
East Asian (EAS)
AF:
1.00
AC:
39552
AN:
39552
South Asian (SAS)
AF:
1.00
AC:
85806
AN:
85808
European-Finnish (FIN)
AF:
1.00
AC:
53250
AN:
53250
Middle Eastern (MID)
AF:
0.999
AC:
5727
AN:
5732
European-Non Finnish (NFE)
AF:
1.00
AC:
1093274
AN:
1093306
Other (OTH)
AF:
0.998
AC:
59617
AN:
59714
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
47
95
142
190
237
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21164
42328
63492
84656
105820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.994
AC:
151333
AN:
152300
Hom.:
75192
Cov.:
31
AF XY:
0.994
AC XY:
74009
AN XY:
74462
show subpopulations
African (AFR)
AF:
0.978
AC:
40642
AN:
41552
American (AMR)
AF:
0.997
AC:
15246
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
1.00
AC:
3472
AN:
3472
East Asian (EAS)
AF:
1.00
AC:
5176
AN:
5176
South Asian (SAS)
AF:
1.00
AC:
4821
AN:
4822
European-Finnish (FIN)
AF:
1.00
AC:
10623
AN:
10624
Middle Eastern (MID)
AF:
1.00
AC:
294
AN:
294
European-Non Finnish (NFE)
AF:
1.00
AC:
68047
AN:
68048
Other (OTH)
AF:
0.995
AC:
2100
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
50
100
151
201
251
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
916
1832
2748
3664
4580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.997
Hom.:
14425
Bravo
AF:
0.993
Asia WGS
AF:
0.996
AC:
3464
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 19, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
6.2
DANN
Benign
0.39
PhyloP100
0.10
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs788238; hg19: chr10-27456003; API